These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36830810)

  • 21. AI-driven attenuation correction for brain PET/MRI: Clinical evaluation of a dementia cohort and importance of the training group size.
    Ladefoged CN; Hansen AE; Henriksen OM; Bruun FJ; Eikenes L; Øen SK; Karlberg A; Højgaard L; Law I; Andersen FL
    Neuroimage; 2020 Nov; 222():117221. PubMed ID: 32750498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
    Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
    Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of
    Sur C; Adamczuk K; Scott D; Kost J; Sampat M; Buckley C; Farrar G; Newton B; Suhy J; Bennacef I; Egan MF
    Mol Imaging Biol; 2022 Dec; 24(6):862-873. PubMed ID: 35794343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface-based partial-volume correction for high-resolution PET.
    Funck T; Paquette C; Evans A; Thiel A
    Neuroimage; 2014 Nov; 102 Pt 2():674-87. PubMed ID: 25175542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DeepPVC: prediction of a partial volume-corrected map for brain positron emission tomography studies via a deep convolutional neural network.
    Matsubara K; Ibaraki M; Kinoshita T;
    EJNMMI Phys; 2022 Jul; 9(1):50. PubMed ID: 35907100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics: a novel feature extraction method for brain neuron degeneration disease using
    Li Y; Jiang J; Lu J; Jiang J; Zhang H; Zuo C
    Ther Adv Neurol Disord; 2019; 12():1756286419838682. PubMed ID: 30956687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation.
    Gutierrez D; Montandon ML; Assal F; Allaoua M; Ratib O; Lövblad KO; Zaidi H
    Comput Med Imaging Graph; 2012 Dec; 36(8):610-9. PubMed ID: 23046730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: comparison with an MR-based method in FDG imaging.
    Ibaraki M; Matsubara K; Shinohara Y; Shidahara M; Sato K; Yamamoto H; Kinoshita T
    Ann Nucl Med; 2022 Aug; 36(8):717-727. PubMed ID: 35616808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new integrated dual time-point amyloid PET/MRI data analysis method.
    Cecchin D; Barthel H; Poggiali D; Cagnin A; Tiepolt S; Zucchetta P; Turco P; Gallo P; Frigo AC; Sabri O; Bui F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2060-2072. PubMed ID: 28674847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between long-term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using
    Li J; Zheng C; Ge Q; Yan S; Paranjpe MD; Hu S; Zhou Y;
    J Neurosci Res; 2022 Feb; 100(2):670-680. PubMed ID: 34882830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.
    Brendel M; Högenauer M; Delker A; Sauerbeck J; Bartenstein P; Seibyl J; Rominger A;
    Neuroimage; 2015 Mar; 108():450-9. PubMed ID: 25482269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification.
    Alongi P; Sardina DS; Coppola R; Scalisi S; Puglisi V; Arnone A; Raimondo GD; Munerati E; Alaimo V; Midiri F; Russo G; Stefano A; Giugno R; Piccoli T; Midiri M; Grimaldi LME
    J Neuroimaging; 2019 May; 29(3):383-393. PubMed ID: 30714241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the partial volume correction method on (18)F-fluorodeoxyglucose brain kinetic modelling from dynamic PET images reconstructed with resolution model based OSEM.
    Bowen SL; Byars LG; Michel CJ; Chonde DB; Catana C
    Phys Med Biol; 2013 Oct; 58(20):7081-106. PubMed ID: 24052021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological Performance Is Correlated With Tau Protein Deposition and Glucose Metabolism in Patients With Alzheimer's Disease.
    Qiao Z; Wang G; Zhao X; Wang K; Fan D; Chen Q; Ai L
    Front Aging Neurosci; 2022; 14():841942. PubMed ID: 35663582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data.
    Rullmann M; McLeod A; Grothe MJ; Sabri O; Barthel H;
    J Nucl Med; 2020 Dec; 61(12):1820-1824. PubMed ID: 32358089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.
    Bevan-Jones WR; Surendranathan A; Passamonti L; Vázquez Rodríguez P; Arnold R; Mak E; Su L; Coles JP; Fryer TD; Hong YT; Williams G; Aigbirhio F; Rowe JB; O'Brien JT
    BMJ Open; 2017 Jan; 7(1):e013187. PubMed ID: 28064175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.